| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PNAS..10819030R |
| P356 | DOI | 10.1073/PNAS.1106408108 |
| P932 | PMC publication ID | 3223430 |
| P698 | PubMed publication ID | 22068912 |
| P5875 | ResearchGate publication ID | 51784712 |
| P50 | author | Stefan Schreiber | Q2337595 |
| Robert Häsler | Q90700457 | ||
| Philip Rosenstiel | Q30089872 | ||
| John F Baines | Q42910589 | ||
| Ateequr Rehman | Q54901257 | ||
| Andre Franke | Q67470670 | ||
| P2093 | author name string | Stephan J Ott | |
| Philipp Rausch | |||
| Sven Künzel | |||
| P2860 | cites work | Variability of human milk neutral oligosaccharides in a diverse population | Q73498151 |
| Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype | Q24315968 | ||
| Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis | Q24537963 | ||
| Diversity of the human intestinal microbial flora | Q24544241 | ||
| Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci | Q24618592 | ||
| A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
| Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities | Q24647611 | ||
| The Ribosomal Database Project (RDP-II): previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy | Q24681903 | ||
| SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB | Q24685829 | ||
| Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model | Q27321389 | ||
| Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
| Human susceptibility and resistance to Norwalk virus infection | Q28190653 | ||
| The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria | Q28594441 | ||
| Unveiling an abundant core microbiota in the human adult colon by a phylogroup-independent searching approach | Q28744074 | ||
| FastTree 2--approximately maximum-likelihood trees for large alignments | Q28748616 | ||
| Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease | Q29417151 | ||
| Search and clustering orders of magnitude faster than BLAST | Q29547431 | ||
| UniFrac: a new phylogenetic method for comparing microbial communities | Q29547435 | ||
| Unravelling the pathogenesis of inflammatory bowel disease | Q29547551 | ||
| Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy | Q29547619 | ||
| Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
| Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. | Q31167835 | ||
| Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease | Q33201542 | ||
| Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis | Q33258217 | ||
| Bias in assessments of marine microbial biodiversity in fosmid libraries as evaluated by pyrosequencing | Q33425675 | ||
| Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data | Q33497123 | ||
| Function-specific response to depletion of microbial diversity | Q33649514 | ||
| Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases | Q33691828 | ||
| A novel mechanism for desulfation of mucin: identification and cloning of a mucin-desulfating glycosidase (sulfoglycosidase) from Prevotella strain RS2 | Q33714457 | ||
| Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis | Q33842489 | ||
| Nod2 is essential for temporal development of intestinal microbial communities. | Q33850984 | ||
| Counting the uncountable: statistical approaches to estimating microbial diversity | Q33990368 | ||
| Microbial community profiling for human microbiome projects: Tools, techniques, and challenges | Q34017154 | ||
| The versatility and adaptation of bacteria from the genus Stenotrophomonas. | Q34987030 | ||
| Influence of the ABO blood groups and secretor status on bleeding and on perforation of duodenal ulcer | Q35003370 | ||
| Association between secretor status and respiratory viral illness | Q35181063 | ||
| Streptococci, ABO blood groups, and secretor status | Q35231959 | ||
| Genetics of Crohn disease, an archetypal inflammatory barrier disease | Q36110574 | ||
| The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats | Q36364133 | ||
| How well do multivariate data sets match? The advantages of a Procrustean superimposition approach over the Mantel test | Q36382581 | ||
| Genes and molecules of lactobacilli supporting probiotic action | Q36995291 | ||
| Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments | Q37039442 | ||
| Analysis of bacterial bowel communities of IBD patients: what has it revealed? | Q37084765 | ||
| Rapid and accurate diagnosis of human intestinal spirochetosis by fluorescence in situ hybridization | Q37191652 | ||
| Widespread gene conversion of alpha-2-fucosyltransferase genes in mammals | Q37252046 | ||
| Targets of balancing selection in the human genome | Q37434392 | ||
| Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection | Q38358090 | ||
| Degradation of blood group antigens in human colon ecosystems. I. In vitro production of ABH blood group-degrading enzymes by enteric bacteria | Q39360757 | ||
| Life-threatening chronic enteritis due to colonization of the small bowel with Stenotrophomonas maltophilia | Q40399327 | ||
| Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa | Q42015583 | ||
| A model of host-microbial interactions in an open mammalian ecosystem | Q42634168 | ||
| A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes | Q43883077 | ||
| Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis | Q44213544 | ||
| Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment | Q44366733 | ||
| A natural history of FUT2 polymorphism in humans. | Q45987241 | ||
| Ancient origin of the null allele se(428) of the human ABO-secretor locus (FUT2). | Q47644378 | ||
| Identification of a new adhesin-like protein from Lactobacillus mucosae ME-340 with specific affinity to the human blood group A and B antigens. | Q48065168 | ||
| Isolation of flagellated bacteria implicated in Crohn's disease. | Q50069322 | ||
| Partitioning diversity into independent alpha and beta components. | Q51698993 | ||
| Bacterial symbionts induce a FUT2-dependent fucosylated niche on colonic epithelium via ERK and JNK signaling. | Q51979421 | ||
| An integrated system for high throughput TaqManTM based SNP genotyping | Q57569262 | ||
| Improving indicator species analysis by combining groups of sites | Q58192868 | ||
| Canonical Correspondence Analysis: A New Eigenvector Technique for Multivariate Direct Gradient Analysis | Q59095599 | ||
| Possible role of blood-group secretory substances in the aetiology of cholera | Q67433050 | ||
| P433 | issue | 47 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 19030-19035 | |
| P577 | publication date | 2011-11-08 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype | |
| P478 | volume | 108 |
| Q91714550 | A Personalised Dietary Approach-A Way Forward to Manage Nutrient Deficiency, Effects of the Western Diet, and Food Intolerances in Inflammatory Bowel Disease |
| Q39455510 | A genome-wide association meta-analysis of diarrhoeal disease in young children identifies FUT2 locus and provides plausible biological pathways. |
| Q21559533 | A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease |
| Q27001407 | A refined palate: bacterial consumption of host glycans in the gut |
| Q36200072 | ABO antigen and secretor statuses are not associated with gut microbiota composition in 1,500 twins |
| Q35597343 | Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms |
| Q46971057 | Aciduric Strains of Lactobacillus reuteri and Lactobacillus rhamnosus, Isolated from Human Feces, Have Strong Adhesion and Aggregation Properties |
| Q37458589 | Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture. |
| Q30903565 | Analysis of intestinal microbiota in hybrid house mice reveals evolutionary divergence in a vertebrate hologenome |
| Q89171051 | Approaches and advances in the genetic causes of autoimmune disease and their implications |
| Q27006589 | Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease |
| Q89072891 | Association analysis of the SNP (rs345476947) in the FUT2 gene with the production and reproductive traits in pigs |
| Q42327964 | Association of Fucosyltransferase 2 Gene Polymorphisms with Inflammatory Bowel Disease in Patients from Southeast China |
| Q36233871 | Association of fucosyltransferase 2 gene variants with ulcerative colitis in Han and Uyghur patients in China |
| Q26782887 | Biliary Mucosal Barrier and Microbiome |
| Q39254939 | Biological functions of fucose in mammals |
| Q36412313 | Boolean analysis reveals systematic interactions among low-abundance species in the human gut microbiome. |
| Q34365119 | Clinical implications of shared genetics and pathogenesis in autoimmune diseases |
| Q90107247 | Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms |
| Q46247311 | Composition and immuno-stimulatory properties of extracellular DNA from mouse gut flora. |
| Q37395969 | Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice |
| Q38172343 | Decoding norovirus infection in Crohn's disease |
| Q38976440 | Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility. |
| Q53828516 | Determinants of IBD Heritability: Genes, Bugs, and More. |
| Q37730870 | Diet and microbiota in inflammatory bowel disease: The gut in disharmony |
| Q33854153 | Dietary history contributes to enterotype-like clustering and functional metagenomic content in the intestinal microbiome of wild mice. |
| Q35231433 | Do the intestinal microbiotas differ between paddlefish (Polyodon spathala) and bighead carp (Aristichthys nobilis) reared in the same pond? |
| Q35607473 | Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. |
| Q34625760 | Environmentally determined differences in the murine lung microbiota and their relation to alveolar architecture |
| Q38985455 | Epithelial glycosylation in gut homeostasis and inflammation |
| Q37196456 | Evaluation of 16S rRNA Gene Primer Pairs for Monitoring Microbial Community Structures Showed High Reproducibility within and Low Comparability between Datasets Generated with Multiple Archaeal and Bacterial Primer Pairs. |
| Q27318788 | Expression of the Blood-Group-Related Gene B4galnt2 Alters Susceptibility to Salmonella Infection |
| Q36101099 | Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci |
| Q41509742 | FUT 2 polymorphism and outcome in very-low-birth-weight infants |
| Q58096391 | FUT2 Genetic Variants and Reported Respiratory and Gastrointestinal Illnesses During Infancy |
| Q51417451 | FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects. |
| Q50223722 | FUT2 non-secretor status is associated with Type 1 diabetes susceptibility in Japanese children |
| Q35147973 | Faecal microbiota composition in adults is associated with the FUT2 gene determining the secretor status. |
| Q64243547 | Fight them or feed them: how the intestinal mucus layer manages the gut microbiota |
| Q34419563 | Friends with social benefits: host-microbe interactions as a driver of brain evolution and development? |
| Q26824328 | From genetics of inflammatory bowel disease towards mechanistic insights |
| Q36136455 | Fucosylation Deficiency in Mice Leads to Colitis and Adenocarcinoma. |
| Q38211812 | Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review |
| Q45375843 | Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis |
| Q38119270 | Genes and functional GI disorders: from casual to causal relationship. |
| Q37730996 | Genetic determinants of serum vitamin B12 and their relation to body mass index |
| Q38610506 | Genetic influences on the human oral microbiome |
| Q34372980 | Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota |
| Q38563101 | Genetics of Inflammatory Bowel Diseases |
| Q59384408 | Genetics of Primary Sclerosing Cholangitis |
| Q39178438 | Genetics of primary sclerosing cholangitis and pathophysiological implications |
| Q39305621 | Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. |
| Q28539941 | Genome-wide association study of metabolic traits reveals novel gene-metabolite-disease links |
| Q36011511 | Gut Immunity and Type 1 Diabetes: a Mélange of Microbes, Diet, and Host Interactions? |
| Q49958101 | Gut microbiota injury in allogeneic haematopoietic stem cell transplantation |
| Q82895213 | Gut microbiota: FUT2 genotype influences the gut microbiota in patients with Crohn's disease and healthy individuals |
| Q26829300 | Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk |
| Q58699643 | Histo-blood group antigen-binding specificities of human rotaviruses are associated with gastroenteritis but not with in vitro infection |
| Q37618401 | Host genetic variation in mucosal immunity pathways influences the upper airway microbiome. |
| Q34908365 | Host genetics and diet, but not immunoglobulin A expression, converge to shape compositional features of the gut microbiome in an advanced intercross population of mice |
| Q38288346 | How do they stick together? Bacterial adhesins implicated in the binding of bacteria to the human gastrointestinal mucins |
| Q92517352 | How the gut microbiome regulates host immune responses to viral vaccines |
| Q41024163 | Human Gut Microbiota: Toward an Ecology of Disease |
| Q34630305 | Human genetics shape the gut microbiome. |
| Q47603312 | IL-17A-Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis. |
| Q34143465 | Immune and genetic gardening of the intestinal microbiome. |
| Q28081984 | Immunogenetic control of the intestinal microbiota |
| Q42242987 | Immunology. Mucus coat, a dress code for tolerance |
| Q35857951 | Immunopathogenesis of IBD: current state of the art. |
| Q28076453 | Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC) |
| Q35044905 | Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease |
| Q57793283 | Impact of high-grain diet feeding on mucosa-associated bacterial community and gene expression of tight junction proteins in the small intestine of goats |
| Q57151899 | Individual variations in cardiovascular-disease-related protein levels are driven by genetics and gut microbiome |
| Q47597465 | Infection's Sweet Tooth: How Glycans Mediate Infection and Disease Susceptibility. |
| Q57056151 | Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies |
| Q26853123 | Inflammatory bowel disease as a model for translating the microbiome |
| Q52665569 | Influence of Novel Highly Pathogenic Avian Influenza A (H5N1) Virus Infection on Migrating Whooper Swans Fecal Microbiota. |
| Q35249518 | Innate lymphoid cells regulate intestinal epithelial cell glycosylation |
| Q41424894 | Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease |
| Q33675239 | Interdisciplinary approach towards a systems medicine toolbox using the example of inflammatory diseases |
| Q39227281 | Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease |
| Q26796606 | Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution? |
| Q97866983 | Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD |
| Q35655273 | Intestinal fucose as a mediator of host-microbe symbiosis. |
| Q36883488 | Intrinsic Defense Mechanisms of the Intestinal Epithelium |
| Q33693158 | Introduction to the human gut microbiota |
| Q37106068 | Isolation of bifidobacteria for blood group secretor status targeted personalised nutrition. |
| Q50970770 | Knockout of the primary sclerosing cholangitis-risk gene Fut2 causes liver disease in mice. |
| Q48123228 | Loss of CNFY toxin-induced inflammation drives Yersinia pseudotuberculosis into persistency. |
| Q35545529 | Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants |
| Q26774688 | Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection |
| Q36072273 | Metagenome-wide association studies: fine-mining the microbiome |
| Q33626199 | Microbial nutrient niches in the gut. |
| Q43631883 | Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency |
| Q56401087 | Microbiome Composition in Both Wild-Type and Disease Model Mice Is Heavily Influenced by Mouse Facility |
| Q38411042 | Mucin glycan foraging in the human gut microbiome. |
| Q37380400 | Mucin-type O-glycans and their roles in intestinal homeostasis |
| Q33775089 | Multigenerational Influences of the Fut2 Gene on the Dynamics of the Gut Microbiota in Mice |
| Q34771641 | New insights on the pathomechanisms of inflammatory bowel disease. |
| Q34369498 | Noninvasive analysis of microbiome dynamics in the fruit fly Drosophila melanogaster |
| Q35657347 | Novel players in coeliac disease pathogenesis: role of the gut microbiota |
| Q52381787 | Of genes and microbes: solving the intricacies in host genomes. |
| Q35853017 | On the origin of species: Factors shaping the establishment of infant's gut microbiota. |
| Q38690443 | Pathogenesis of ankylosing spondylitis - recent advances and future directions. |
| Q33758469 | Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies |
| Q56442935 | Primary Sclerosing Cholangitis |
| Q56442936 | Primary sclerosing cholangitis |
| Q52859380 | Psoriasis and inflammatory bowel disease: links and risks. |
| Q34596752 | Reciprocal interaction between intestinal microbiota and mucosal lymphocyte in cynomolgus monkeys after alemtuzumab treatment |
| Q38678117 | Relationships between gastrointestinal microbiota and blood group antigens |
| Q37728352 | Relevance of secretor status genotype and microbiota composition in susceptibility to rotavirus and norovirus infections in humans |
| Q35159836 | Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism |
| Q42174395 | Role of the microbiota and antibiotics in primary sclerosing cholangitis |
| Q61805532 | SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects |
| Q47098418 | Seasonal, spatial, and maternal effects on gut microbiome in wild red squirrels |
| Q98612722 | Secondary causes of inflammatory bowel diseases |
| Q35731477 | Secretor Status Is Strongly Associated with Microbial Alterations Observed during Pregnancy |
| Q39211334 | Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome. |
| Q90171001 | Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection |
| Q37214656 | Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts |
| Q57140500 | Stable-Isotope Probing of Human and Animal Microbiome Function |
| Q35942610 | The Cholangiopathies |
| Q37620525 | The Fecal Microbial Community of Breast-fed Infants from Armenia and Georgia. |
| Q28085346 | The Immunogenetics of Autoimmune Cholestasis |
| Q35710401 | The Influence of the Autoimmunity-Associated Ancestral HLA Haplotype AH8.1 on the Human Gut Microbiota: A Cross-Sectional Study |
| Q52679195 | The Interactions between Host Glycobiology, Bacterial Microbiota, and Viruses in the Gut. |
| Q35044607 | The composition of the gut microbiota throughout life, with an emphasis on early life. |
| Q34616316 | The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease |
| Q34624820 | The genetic predisposition and the interplay of host genetics and gut microbiome in Crohn disease |
| Q38293761 | The genetics of Crohn's disease and ulcerative colitis--status quo and beyond |
| Q26992279 | The genetics of complex cholestatic disorders |
| Q33664898 | The microbiome in inflammatory bowel disease: current status and the future ahead |
| Q33806817 | The microbiota in inflammatory bowel disease: current and therapeutic insights |
| Q26783887 | The mucosal immune system: From dentistry to vaccine development |
| Q37242662 | The role of ABO blood groups in Crohn's disease and in monitoring response to infliximab treatment |
| Q43483530 | The role of biogeography in shaping diversity of the intestinal microbiota in house mice |
| Q90364948 | The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia |
| Q42778188 | Transcriptomic Landscape of Treatment - Naïve Ulcerative Colitis |
| Q34384544 | Use of animal models in elucidating disease pathogenesis in IBD. |
| Q26853628 | Use of gnotobiotic mice to identify and characterize key microbes responsible for the development of the intestinal immune system |
| Q26782991 | Using GWAS to identify genetic predisposition in hepatic autoimmunity |
Search more.